Skip to main content

ABVX · Abivax S.A. · Financials

Track ABVX — free
$88.01 -2.22 (-2.46%) At close · Oct 23
Market Cap
$7.64B
Shares
87.27M
Volume · Oct 23 432.49K Avg daily vol (3M) 1.13M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
4.57M -63.3%
FY2025 Revenue FY2021–FY2025
Net Income
-336.1M -90.7%
FY2025 Net Income FY2021–FY2025
Operating Margin
-5384.16% -3994.6pp
FY2025 Operating Margin FY2021–FY2025
Diluted EPS
-4.83 -72.5%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-161.13M -4.6%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
EUR 4.57M 12.45M 4.62M 4.58M 11.96M
EUR 177.76M 146.53M 103.18M 48.3M 47.78M
EUR 5.19M 5.95M 6.43M 0 0
EUR 67.67M 32.95M 22.39M 7.49M 5.58M
EUR -246.06M -172.98M -127.38M -64.84M -41.4M
EUR 111.74M 16.99M 27.88M 7.02M 3.56M
EUR -330.25M -176.24M -147.74M -60.74M -42.45M
EUR 5.85M 0 0 0 0
EUR -336.1M -176.24M -147.74M -60.74M -42.45M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2026-06-30 EUR 1,212,000 6-K filed 2026-09-21
Other current borrowings 2026-06-30 EUR 1,075,000 6-K filed 2026-09-21
Other noncurrent borrowings 2026-06-30 EUR 137,000 6-K filed 2026-09-21
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1956827 CUSIP 00370M103 13F (30d) 40 filings 40 filers Visit website Investor relations